
FDA Approves At-Home Leqembi Treatment for Alzheimer’s
Eligible patients can now begin Leqembi treatment at home, potentially reducing repeated infusion-center visits while preserving essential medical supervision and safety monitoring.

Eligible patients can now begin Leqembi treatment at home, potentially reducing repeated infusion-center visits while preserving essential medical supervision and safety monitoring.

MEDICATION: Razadyne (generic galantamine) is an FDA-Approved daffodil extract for Alzheimer’s. Learn how it significantly lowered mortality & eased cognitive decline.

MEDICATION VIDEO: Aricept® (generic DONEPEZIL) is the world’s most popular drug for Early-stage Alzheimer’s. Does it help in Advanced-stage Alzheimer’s?

COCHRANE SERIES, PART 3 – DEEP DIVE: False alarm. The Cochrane Review shook confidence in Leqembi. It rests on a scientific threshold its own source publicly disowned. Here’s why the evidence did not justify the alarm.

COCHRANE SERIES, PART 2 – HOW IT HAPPENED: A new review just went viral in the media, declaring Alzheimer’s drugs don’t work. Leading scientists say the methodology was fundamentally flawed.

COCHRANE SERIES, PART 1 – WHAT HAPPENED:
A respected review called a breakthrough Alzheimer’s drug useless. Experts shrugged. Investors, who normally panic on such news, barely noticed. Here’s why that matters — and what it means for families weighing their options.

CLINICAL INERTIA is when it’s much easier to start someone on a medication, and keep them on, than to take them off. Find out why most advanced dementia patients receive too many expensive, questionable medications.

In a new deal with Alloy Therapeutics, Biogen—the makers of Leqembi—is investing in RNA technology that could point toward what comes next in Alzheimer’s care.

Could Leqembi be given faster and more easily in the future? The new Biogen–Alteogen deal suggests it’s possible—but it doesn’t confirm changes to Leqembi. Here’s what professionals and families should understand.

The diagnostic and treatment network behind Leqembi may be its biggest competitive edge.

INSPIRING VIDEO:
Over the years, this video has lifted thousands with Alzheimer’s. David Gary Quinton speaks candidly about his life with dementia. See how he and his wife stay upbeat and prepare for changes ahead. Hear Quinton talk passionately about his decision to maximize life and live it to the fullest.

With all the information out there about Alzheimer’s, it’s hard to tease out which things are true, and which things are not. Some “facts” are really just myths. Find out which is which.

In turns heartbreaking and inspiring, the movie “Still Alice” captures in remarkable detail what’s it’s like to live with Alzheimer’s.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!

It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.



We use cookies and similar technologies to improve your experience, understand how our content is used, and support relevant advertising that helps keep Alzheimer’s Weekly free to readers. You can choose to accept, deny, or manage your preferences at any time. Declining certain cookies may affect features such as embedded videos, comments, and personalized advertising.